Healthcare data startup Talking Medicines has been announced the winner of FutureX’s Startup Summit Competition, following a live pitch battle in front of 1,000 delegates at this year’s Startup Summit in Edinburgh.
Dr Elizabeth Fairley, co-founder and COO of Talking Medicines, successfully fended off strong competition from fellow finalists to secure the competition’s grand prize of £200,000 for her company.
The finalists were selected from more than 100 applicants from across the UK and industries spanning healthcare, advertising and communications. In the penultimate round of the pitching, Fairley went up against Daniel Winterstein, founder and CTO of Good-Loop, and Pasquale Saviano, CEO and founder at Photocert.
Fairley and Talking Medicine will now benefit from a business support package worth more than £220k from Johnston Carmichael, AAI EmployAbility, STV, The Herald, Dentsu Aegis Network and IBM. As part of the prize, Fairley has secured a fully funded place on FutureX’s Silicon Valley Accelerate programme, which takes a select group of rising UK tech leaders to Silicon Valley.
Once there, the programme provides participants with the opportunity to connect with leading global players in the tech industry and to pitch to potential investors. Previous cohorts have met with executives from Airbnb, Facebook, SurveyMonkey, RocketSpace, Y Combinator, Waze and Threshold.
- UK Government Leads the Way in AI Investment
- Russia’s Controversial “Sovereign Internet Law” Comes into Force
- Abertay University Partnership Helps Protect Kids in Online Games
Fairley said of her win: “We are so excited to have won the Startup Summit Competition. It is fantastic timing for us as we raise our profile and mission to capture the voice of the patient and drive the effective use of medicines around the world. We are delighted to be partnering with media companies STV and Dentsu Aegis Network – with their support, we will have a much stronger voice.
“We are excited about our trip to the US as we love the fast pace and can-do attitude there. We look forward to broadening our network, and meeting with investors and potential exit partners.”
Zoi Kantounatou, co-founder and CFO of FutureX, said: “All of the finalists deserved to be on our Silicon Valley Accelerate programme. The judges had an unenviable task of choosing the winner! I am excited to have Elizabeth join the programme and I look forward to seeing where the opportunity takes her and Talking Medicines.”
FutureX’s co-founder and CEO, Bruce Walker, said: “The introduction of the tech for good criterion this year took the competition to another level. As we become more reliant on tech in our lives, we have to consider the opportunities and risks that dependency creates. Elizabeth, and each of the finalists, epitomise how tech can create a positive impact on the people around us.”